Company Description
Novanta Inc., together with its subsidiaries, provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally.
The company operates through three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation.
The Precision Medicine and Manufacturing segment offers photonics-based solutions, including laser scanning, beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures.
The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; wireless technologies, video recorders, and video integration technologies for operating room integrations; optical data collection and machine vision technologies; radio frequency identification technologies; thermal chart recorders; spectrometry technologies; and embedded touch screen solutions.
The Robotics and Automation segment offers optical and inductive encoders, precision motors, servo drives and motion control solutions, integrated stepper motors, intelligent robotic end-of-arm technology solutions, air bearings, and air bearing spindles.
The company sells its products through its direct sales force and distributors under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, General Scanning, ATI Industrial Automation, Celera Motion, IMS, MicroE, Applimotion, Zettlex, Ingenia, and Westwind brands.
The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016.
Novanta Inc. was incorporated in 1968 and is headquartered in Bedford, Massachusetts.
| Country | United States |
| Founded | 1968 |
| Industry | Scientific & Technical Instruments |
| Sector | Technology |
| Employees | 2,900 |
| CEO | Matthijs Glastra |
Contact Details
Address: 125 Middlesex Turnpike, . Bedford, Massachusetts 01730 United States | |
| Phone | 781-266-5618 |
| Website | novanta.com |
Stock Details
| Ticker Symbol | NOVT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001076930 |
| CUSIP Number | 67000B104 |
| ISIN Number | CA67000B1040 |
| Employer ID | 98-0110412 |
| SIC Code | 3690 |
Key Executives
| Name | Position |
|---|---|
| Matthijs Glastra | Chief Executive Officer and Chairman of the Board |
| Robert J. Buckley | Chief Financial Officer |
| Michele Davis Michele Welsh | General Counsel and Corporate Secretary |
| Brian S. Young | Chief Human Resources Officer |
| Peter L. Chang | Corporate Controller and Chief Accounting Officer |
| Sarah Betadam | Chief Information Officer and Chief Information Security Officer |
| Charlie Webster | Executive Vice President of Novanta Growth System and Global Supply Chain |
| Chuck Ravetto | Group President of Automation Enabling Technologies Group |
| Anna Fain | Senior Vice President of Leadership Development and Diversity, Equity and Inclusion |
| Heinrich Dreyer | Group President of Medical Solutions |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 3, 2024 | ARS | Filing |
| Apr 3, 2024 | DEF 14A | Other definitive proxy statements |
| Apr 1, 2024 | 144 | Filing |
| Mar 15, 2024 | 8-K | Current Report |
| Mar 1, 2024 | 144 | Filing |
| Feb 28, 2024 | 10-K | Annual Report |
| Feb 28, 2024 | 8-K | Current Report |
| Feb 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Feb 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jan 23, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |